Porvair Sciences reports on the installation of new automated precision die-cutting equipment that has enabled a five-fold increase in its production capacity for porous plastic components.

Origin Therapeutics Holdings Inc. an actively managed investment issuer focused on making equity investments in psychedelics-related companies, is pleased to announce its launch.

BÜCHI Labortechnik AG has launched two new product lines for steam distillation with innovative, modular features that provide the highest flexibility in analyte determination.

Paradigm4 has launched its REVEALTM: Multi-Omics app, allowing researchers to undertake advanced, cross-study analyses and enable quick searches for genes and proteins across all integrated public reference and proprietary datasets.

HORIBA UK announces the first UK installation of its Fluorolog-QM modular research-grade fluorescence spectrometer. The spectrometer will form an integral part of research into novel fluorophores by Dr Marc Etherington of Northumbria University.

Fusion Antibodies and BioTickle are providing local biopharmaceutical organizations with access to invaluable unique biopharmaceutical development capabilities.

Autoscribe Informatics has released a new veterinary laboratory case study focusing on the benefits that Matrix Gemini LIMS has bought to Scone Equine Hospital. The LIMS is in daily use in the largest equine veterinary practice in Australia.

Orbit Discovery Ltd. has announced that it has raised $7.6 million (USD) in funding.

Owlstone Medical has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs.

Lonza and CN Bio have entered into a distribution agreement whereby Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in their PhysioMimix™ Single-and Multi-Organ MPS to transform the way human-relevant pre-clinical data is generated.